American International Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,161
| Closed | -$132 | – | 3189 |
|
|
2020
Q4 | $132 | Sell |
7,161
-207
| -3% | -$4 | ﹤0.01% | 2511 |
|
|
2020
Q3 | $135K | Sell |
7,368
-167
| -2% | -$3.06K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $113K | Buy |
7,535
+372
| +5% | +$5.58K | ﹤0.01% | 2463 |
|
|
2020
Q1 | $113K | Sell |
7,163
-414
| -5% | -$6.53K | ﹤0.01% | 2239 |
|
|
2019
Q4 | $123K | Sell |
7,577
-63
| -0.8% | -$1.02K | ﹤0.01% | 2503 |
|
|
2019
Q3 | $114K | Sell |
7,640
-54
| -0.7% | -$806 | ﹤0.01% | 2528 |
|
|
2019
Q2 | $127K | Buy |
7,694
+294
| +4% | +$4.85K | ﹤0.01% | 2528 |
|
|
2019
Q1 | $128K | Sell |
7,400
-239
| -3% | -$4.13K | ﹤0.01% | 2478 |
|
|
2018
Q4 | $135K | Sell |
7,639
-58
| -0.8% | -$1.03K | ﹤0.01% | 2427 |
|
|
2018
Q3 | $140K | Buy |
7,697
+138
| +2% | +$2.51K | ﹤0.01% | 2647 |
|
|
2018
Q2 | $148K | Buy |
+7,559
| New | +$148K | ﹤0.01% | 2550 |
|
|
2017
Q2 | – | Sell |
-7,487
| Closed | -$88K | – | 3149 |
|
|
2017
Q1 | $88K | Buy |
7,487
+496
| +7% | +$5.83K | ﹤0.01% | 2657 |
|
|
2016
Q4 | $92K | Sell |
6,991
-19
| -0.3% | -$250 | ﹤0.01% | 2652 |
|
|
2016
Q3 | $102K | Buy |
7,010
+10
| +0.1% | +$145 | ﹤0.01% | 2588 |
|
|
2016
Q2 | $83.9K | Buy |
7,000
+1,238
| +21% | +$14.8K | ﹤0.01% | 2734 |
|
|
2016
Q1 | $107K | Hold |
5,762
| – | – | ﹤0.01% | 3377 |
|
|
2015
Q4 | $124K | Sell |
5,762
-10
| -0.2% | -$215 | ﹤0.01% | 3312 |
|
|
2015
Q3 | $98K | Buy |
5,772
+6
| +0.1% | +$102 | ﹤0.01% | 3499 |
|
|
2015
Q2 | $216K | Buy |
+5,766
| New | +$216K | ﹤0.01% | 2941 |
|